nach oben

Erschienen in:

2017 | OriginalPaper | Buchkapitel

1. Antidepressiva

verfasst von : Dr. med. F. Regen, Prof. Dr. med. O. Benkert

Erschienen in: Kompendium der Psychiatrischen Pharmakotherapie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Antidepressiva sind eine heterogene Gruppe von Pharmaka, die bei depressiven Syndromen unterschiedlicher nosologischer Zuordnung und Charakteristik einen stimmungsaufhellenden und/oder antriebsverbessernden Therapieeffekt haben. Zusätzlich sind sie bei einer Reihe weiterer Störungsbilder wirksam, sodass der Begriff »Antidepressiva« nur einen Teilaspekt ihrer therapeutischen Potenz darstellt.

Aan het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72(7): 537–547

Appleton KM, Sallis HM, Perry R et al (2015) Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev 11: CD004692

Arnow BA, Blasey C, Williams LM et al (2015) Depression subtypes in predicting antidepressant response: a report from the iSPOT-D Trial. Am J Psychiatry 172(8): 743–750

Benkert O (2009) StressDepression. Beck, München

Brunoni AR, Valiengo L, Baccaro A et al (2013) The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 70(4): 383–391

Cipriani A, Purgato M, Furukawa TA et al (2012) Citalopram versus other anti-depressive agentsfor depression. Cochrane Database Syst Rev 7: CD006534

Cooney GM, Dwan K, Greig CA et al (2013) Exercise for depression. Cochrane Database Syst Rev 9: CD004366

Cuijpers P, Sijbrandij M, Koole SL et al (2013) The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 12(2): 137–148

Cuijpers P, Sijbrandij M, Koole SL et al (2014) Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 13(1): 56–67

DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg) für die Leitliniengruppe Unipolare Depression (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Aufl. Version 2. www.depression.versorgungsleitlinien.de (Online-Zugriff: 10.03.2016)

Diener H-C, Weimar C (Hrsg) (2012) Leitlinien für Diagnostik und Therapie in der Neurologie. Herausgegeben von der Kommission »Leitlinien« der Deutschen Gesellschaft für Neurologie, Thieme, Stuttgart

Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 16(3): 557–574

Dougherty DD, Rezai AR, Carpenter LL et al (2015) A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry 78(4): 240–248

Driessen E, Hollon SD, Bockting CL et al (2015) Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of Health-funded trials. PLoS One 10(9): e0137864

Fava M, Memisoglu A, Thase ME et al (2016) Opioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial. Am J Psychiatry 173(5): 499-508

Feder A, Parides MK, Murrough JW et al (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71(6): 681–698

Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14(2): 162–173

Gartlehner G, Hansen RA, Morgan LC et al (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155(11): 772–875

Guidi J, Tomba E, Fava GA (1026) The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psych 173(2): 128–137

Gustafsson H, Nordström A, Nordström P (2015) Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology 84(24): 2422–2429

Hackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79(18): 1862–1865

Hiemke C, Baumann P, Bergemann N et al (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6): 195–235

Hollon SD, DeRubeis RJ, Fawcett J et al (2014) Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71(10): 1157–1164

Hoskins M, Pearce J, Bethell A et al (2015) Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry 206(2): 93–100

Jakubovski E, Varigonda AL, Freemantle N et al (2016) Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry 173(2): 174–183

Jarrett RB, Minhajuddin A, Gershenfeld H et al (2013) Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 70(11): 1152–1160

Katon W, Pedersen HS, Ribe AR et al (2015) Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 72(6): 612–619

Kiosses DN, Ravdin LD, Gross JJ et al (2015) Problem adaptation therapy for older adults with major depression and cognitive impairment: a randomized clinical trial. JAMA Psychiatry 72(1): 22–30

Koenen KC, Uddin M, Chang SC et al (2011) SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety 28(8): 639–647

Köhler O, Benros ME, Nordentoft M et al (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71(12): 1381–1391

Kok RM, Nolen WA, Heeren TJ (2012) Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 141(2–3): 103–115

Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52(Suppl 5): 28–34

Kuyken W, Hayes R, Barrett B et al (2015) Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet 386(9988): 63–73

Lam RW, Levitt AJ, Levitan RD et al (2016) Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial. JAMA Psychiatry 73(1): 56–63

Lapidus KA, Levitch CF, Perez AM et al (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76(12): 970–976

Mayo-Wilson E, Dias S, Mavranezouli I et al (2014) Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry 1(5): 368–376

McAllister-Williams RH, Anderson IM et al (2016) Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. Lancet Psychiatry 3(2): 117–127

Mead GE, Hsieh CF, Lee R et al (2013) Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke 44(3): 844–850

Miller M, Swanson SA, Azrael D et al (2014) Antidepressant Dose, Age, and the Risk of Deliberate Self-harm. JAMA Intern Med 174(6): 899–909

Mortensen JK, Larsson H, Johnsen SP, Andersen G (2013) Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 44(2): 420–442

Nagele P, Duma A, Kopec M et al (2015) Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial. Biol Psychiatry 78(1): 10–18

Nelson JC, Delucchi KL, Schneider LS (2013) Moderators of outcome in late-life depression: a patient-level meta-analysis. Am J Psychiatry 170(6): 651–659

Ostad Haji E, Mann K, Dragicevic A et al (2013) Potential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopram. Ther Drug Monit 35(3) :396–401

Porsteinsson AP, Drye LT, Pollock BG et al; CitAD Research Group (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311(7): 682–691

Sharma T, Guski LS, Freund N, Gøtzsche PC (2016) Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 352: i65

Simpson HB, Foa EB, Liebowitz MR et al (2013) Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 70(11): 1190–1199

Stewart JW, McGrath PJ, Blondeau C et al (2014) Combination antidepressant therapy for major depressive disorder: Speed and probability of remission. J Psychiatr Res 57: 7–14

Stingl JC, Brockmöller J (2013) Personalisierte Pharmakotherapie. Evidenzbasierte Leitlinien und klinische Anwendung pharmakogenetischer Diagnostik. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(11): 1509–1521

Tadić A, Wachtlin D, Berger M et al (2016) Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial. Eur Neuropsychopharmacol 26(4): 705–716

Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-Induced Liver Injury: A Review for Clinicians. Am J Psychiatry 171(4): 404–415

von Wolff A, Hölzel LP, Westphal A et al (2013) Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J Affect Disord 144(1–2): 7–15

Wang YP, Chen YT, Tsai CF et al (2014) Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry 171(1): 54–61

Watts BV, Schnurr PP, Mayo L et al (2013) Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry 74(6): e541–550

Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsades de Pointes. Dtsch Arztebl Int 108(41): 687–693

WHO (World Health Organization and United Nations High Commissioner for Refugees) (2013) Assessment and Management of Conditions Specifically Related to Stress: mhGAP Intervention Guide Module (version 1.0). Geneva

Zhou X, Ravindran AV, Qin B et al (2015) Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry 76(4): e487–98

Titel: Antidepressiva
verfasst von: Dr. med. F. Regen
Prof. Dr. med. O. Benkert
Verlag: Springer Berlin Heidelberg
Buch: Kompendium der Psychiatrischen Pharmakotherapie
Print ISBN: 978-3-662-50332-4

Electronic ISBN: 978-3-662-50333-1

Copyright-Jahr: 2017
DOI: https://doi.org/10.1007/978-3-662-50333-1_1

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

1. Antidepressiva

Zusammenfassung

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt